GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,036 Cr | ₹928 Cr | ₹590 Cr | ₹611 Cr | ₹1,695 Cr |
What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹1,036 Cr |
| Mar2025 | ₹928 Cr |
| Mar2024 | ₹590 Cr |
| Mar2023 | ₹611 Cr |
| Mar2022 | ₹1,695 Cr |
How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,036 Cr | 11.69 | |
| Mar2025 | ₹928 Cr | 57.23 | |
| Mar2024 | ₹590 Cr | -3.39 | |
| Mar2023 | ₹611 Cr | -63.97 | |
| Mar2022 | ₹1,695 Cr | - | |
Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,771.0 Cr | -0.1% | -4.1% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.1% |
-4.1% |
-4.7% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses